Disease: squamous cell lung cancer  
NumberOfSamples: cohort of 108 squamous cell lung cancer (SCC) patients  
Specimen: snap frozen tumor tissues  
Specimen: formalin fixed paraffin embedded sample  
TumorStage: stage I–III  
AssayName: RNA-sequencing  
AssayName: expression proteomics  
AssayName: liquid chromatography-tandem mass spectrometry (LC-MS/MS)  
AssayName: RNAseq  
AssayName: Targeted exome sequencing of 154 genes  
Instrument: BioPulverizer (Biospec)  
Instrument: Dionex Ultimate3000 RSLC UPLC  
Instrument: Q Exactive Plus  
Instrument: Covaris M220  
Instrument: Affymetrix CytoScan HD Assay  
Instrument: Illumina NextSeq 500  
ReductionReagent: DTT  
AlkylationReagent: iodoacetamide  
CleavageAgent: trypsin  
FractionationMethod: bRPLC separation  
FlowRateChromatogram: 300 nl/min  
GradientTime: 90 min gradient  
PooledSample: two tumor pool replicates  
Label: tandem mass tag (TMT)  
AcquisitionMethod: data independent acquisition (DIA)  
SpikedCompound: standard peptides (PRTC)  
Separation: C18 reversed-phase resin  
ConcentrationOfCompound: 4.5 mM DTT  
ConcentrationOfCompound: 11 mM iodoacetamide  
ConcentrationOfCompound: final TFA concentration of 1%  
Temperature: 60 °C  
Temperature: room temperature  
Time: overnight at 37 °C  
EnrichmentMethod: tandem mass tag (TMT) chemical labeling experiments